Olic (Thailand)
Thailand 68 employees Updated 9 July 2026
Olic (Thailand) is a finished-dose manufacturer based in Thailand. It appears in 11 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY) and EDE (AE). Its most recent recorded inspection, by US FDA, closed on 28 October 2022 as NAI.
3
registered plants
1 with an FDA FEI number
11
filings
across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 28 October 2022 NAI US FDA
- 22 November 2018 NAI US FDA
- 18 November 2016 VAI US FDA
- 2 May 2014 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| BANGPA-IN, United Arab Emirates | Not on file |
| AYUTTHAYA, PHRA NAKHON SI, Thailand | Not on file |
| Thailand, Thailand | 3004039360 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| NPRA (MY) | 10 | None |
| EDE (AE) | 1 | None |
Comparing suppliers?
Choose your molecules and target markets. Olic (Thailand) comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 28 October 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability